摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl-3-deoxy-erythro-α-D-pentofuranosid | 42890-91-5

中文名称
——
中文别名
——
英文名称
Methyl-3-deoxy-erythro-α-D-pentofuranosid
英文别名
(2S,3R,5S)-5-(hydroxymethyl)-2-methoxyoxolan-3-ol
Methyl-3-deoxy-erythro-α-D-pentofuranosid化学式
CAS
42890-91-5
化学式
C6H12O4
mdl
——
分子量
148.159
InChiKey
XFLOJOXQDZMCRP-JKUQZMGJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    294.5±40.0 °C(Predicted)
  • 密度:
    1.24±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    58.9
  • 氢给体数:
    2
  • 氢受体数:
    4

文献信息

  • Synthesis of beta-L-2'-deoxy nucleosides
    申请人:Storer Richard
    公开号:US20050059632A1
    公开(公告)日:2005-03-17
    An improved process for the preparation of 2′-modified nucleosides and 2′-deoxy-nucleosides, such as, β-L-2′-deoxy-thymidine (LdT), is provided. In particular, the improved process is directed to the synthesis of a 2′-deoxynucleoside that may utilize different starting materials but that proceeds via a chloro-sugar intermediate or via a 2,2′-anhydro-1-furanosyl-nucleobase intermediate. Where an 2,2′-anhydro- 1 -furanosyl base intermediate is utilized, a reducing agent, such as Red-Al, and a sequestering agent, such as 15-crown-5 ether, that cause an intramolecular displacement reaction and formation of the desired nucleoside product in good yields are employed. An alternative process of the present invention utilizes a 2,2′-anhydro-1-furanosyl base intermediate without a sequestering agent to afford 2′-deoxynucleosides in good yields. The compounds made according to the present invention may be used as intermediates in the preparation of other nucleoside analogues, or may be used directly as antiviral and/or antineoplastic agents.
    提供了一种改进的2'-改性核苷和2'-脱氧核苷的制备工艺,例如,β-L-2'-脱氧胸苷(LdT)。特别是,改进的工艺针对的是2'-脱氧核苷的合成,该合成可能使用不同的起始材料,但都通过糖中间体或通过2,2'-脱-1-呋喃核苷中间体进行。当使用2,2'-脱-1-呋喃糖碱基中间体时,会采用还原剂(如Red-Al)和隔离剂(如15-冠-5醚),它们能引起分子内位移反应,并形成所需核苷产品的高收率。本发明的一种替代工艺使用2,2'-脱-1-呋喃糖碱基中间体而不使用隔离剂,也能以高收率获得2'-脱氧核苷。根据本发明制成的化合物可以作为制备其他核苷类似物的中间体,或者可以直接用作抗病毒和/或抗肿瘤剂。
  • Synthesis of beta-L-2-Deoxy nucleosides
    申请人:Novartis AG
    公开号:EP2157095A2
    公开(公告)日:2010-02-24
    An improved process for the preparation of 2'-modified nucleosides and 2'-deoxynucleosides, such as, β-L-2'-deoxy-thymidine (LdT), is provided. In particular, the improved process is directed to the synthesis of a 2'-deoxynucleoside that may utilize different starting materials but that proceeds via a chloro-sugar intermediate or via a 2,2' anhydro-1-furanosyl-nucleobase intermediate. Where an 2,2'-anhydro-1-furanosyl base intermediate is utilized, a reducing agent, such as Red-Al, and a sequestering agent, such as 15-crown-5 ether, that cause an intramolecular displacement reaction and formation of the desired nucleoside product in good yields are employed. An alternative process of the present invention utilizes a 2,2'-anhydro-1-furanosyl base intermediate without a sequestering agent to afford 2'-deoxynucleosides in good yields. The compounds made according to the present invention may be used as intermediates in the preparation of other nucleoside analogues, or may be used directly as antiviral and/or antineoplastic agents.
    本发明提供了一种改进的方法,用于制备2'-修饰核苷和2'-去氧核苷,例如β-L-2'-去氧胸腺嘧啶(LdT)。特别是,改进的方法针对合成一种2'-去氧核苷,该方法可以利用不同的起始材料,但是通过代糖中间体或2,2'无-1-呋喃基-核碱中间体进行。当使用2,2'-无-1-呋喃基碱中间体时,采用还原剂(如Red-Al)和隔离剂(如15-冠-5醚),引起分子内位移反应并形成所需的核苷产物,产率良好。本发明的另一种替代方法利用无隔离剂的2,2'-无-1-呋喃基碱中间体,以获得良好的2'-去氧核苷收率。根据本发明制备的化合物可以用作制备其他核苷类似物的中间体,或者可以直接用作抗病毒和/或抗肿瘤剂。
  • [EN] SYNTHESIS OF beta-L-2-DEOXY NUCLEOSIDES<br/>[FR] SYNTHESE DE NUCLEOSIDES 20050113See references of EP 1639121A4
    申请人:IDENIX CAYMAN LTD
    公开号:WO2005003374A2
    公开(公告)日:2005-01-13
    An improved process for the preparation of 2'-modified nucleosides and 2'-deoxy-nucleosides, such as, β-L-2'-deoxy-thymidine (LdT), is provided. In particular, the improved process is directed to the synthesis of a 2'-deoxynucleoside that may utilize different starting materials but that proceeds via a chloro-sugar intermediate or via a 2,2'­ anhydro-1-furanosyl-nucleobase intermediate. Where an 2,2'-anhydro-1-furanosyl base intermediate is utilized, a reducing agent, such as Red-Al, and a sequestering agent, such as 15-crown-5 ether, that cause an intramolecular displacement reaction and formation of the desired nucleoside product in good yields are employed. An alternative process of the present invention utilizes a 2,2'-anhydro-1-furanosyl base intermediate without a sequestering agent to afford 2'-deoxynucleosides in good yields. The compounds made according to the present invention may be used as intermediates in the preparation of other nucleoside analogues, or may be used directly as antiviral and/or antineoplastic agents.
    提供了一种改进的制备2'-修饰核苷和2'-脱氧核苷(例如β-L-2'-脱氧胸腺嘧啶(LdT))的方法。特别是,改进的方法是针对合成2'-脱氧核苷的,可以利用不同的起始材料,但是通过代糖中间体或2,2'-无-1-呋喃核碱中间体进行。当使用2,2'-无-1-呋喃基中间体时,采用还原剂(如Red-Al)和隔离剂(如15-冠-5醚)引起分子内置换反应并形成所需的核苷产物,产率较高。本发明的另一种替代方法利用2,2'-无-1-呋喃基中间体而不使用隔离剂,可以获得产率较高的2'-脱氧核苷。根据本发明制备的化合物可以用作其他核苷类似物的中间体,或者可以直接用作抗病毒和/或抗肿瘤剂。
  • Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method
    申请人:Culbertson Sean M.
    公开号:US20110230618A1
    公开(公告)日:2011-09-22
    Provided herein are polymeric α-hydroxy aldehyde or α-hydroxy ketone reagents which can be conjugated to amine-containing compounds to form stable conjugates in a single-step reaction. In selected embodiments, the polymeric reagent itself incorporates an internal proton-abstracting (basic) functional group, to promote more efficient reaction. The substituent is appropriately situated, via a linker if necessary, to position the group for proton abstraction, preferably providing a 4- or 5-bond spacing between the abstracting atom and the hydrogen atom on the α-carbon. Also provided are methods of using the reagents and stable, solubilized conjugates of the reagents with biologically active compounds. In preferred embodiments, the polymeric component of the reagent or conjugate is a polyethylene glycol.
    本文提供了聚合物α-羟基醛或α-羟基酮试剂,可以与含胺化合物共轭,在单步反应中形成稳定的共轭物。在选定的实施例中,聚合物试剂本身包含内部质子抽取(碱性)功能基团,以促进更有效的反应。通过连接剂必要时适当地定位取代基,以定位功能基团进行质子抽取,最好在α-碳上的氢原子和抽取原子之间提供4或5键间隔。还提供使用试剂的方法以及与生物活性化合物稳定、可溶化的共轭物。在优选实施例中,试剂或共轭物的聚合物组分是聚乙二醇
  • POLYMERIC ALPHA-HYDROXY ALDEHYDE AND KETONE REAGENTS AND CONJUGATION METHOD
    申请人:NEKTAR THERAPEUTICS
    公开号:US20130280783A1
    公开(公告)日:2013-10-24
    Provided herein are polymeric α-hydroxy aldehyde or α-hydroxy ketone reagents which can be conjugated to amine-containing compounds to form stable conjugates in a single-step reaction. In selected embodiments, the polymeric reagent itself incorporates an internal proton-abstracting (basic) functional group, to promote more efficient reaction. The substituent is appropriately situated, via a linker if necessary, to position the group for proton abstraction, preferably providing a 4- or 5-bond spacing between the abstracting atom and the hydrogen atom on the α-carbon. Also provided are methods of using the reagents and stable, solubilized conjugates of the reagents with biologically active compounds. In preferred embodiments, the polymeric component of the reagent or conjugate is a polyethylene glycol.
    本文提供了聚合物α-羟基醛或α-羟基酮试剂,可以与含胺化合物结合,形成稳定的共轭物,在单步反应中完成。在选定的实施例中,聚合物试剂本身包含一个内部质子抽取(碱性)功能基团,以促进更有效的反应。适当的取代基通过连接基团等方式进行定位,以将基团定位于质子抽取位置,最好在α-碳上的氢原子和抽取原子之间提供4或5键间隔。还提供了使用这些试剂和与生物活性化合物稳定、可溶化的共轭物的方法。在首选实施例中,试剂或共轭物的聚合物部分是聚乙二醇
查看更多

同类化合物

顺式-4-氨基-四氢呋喃-3-醇 顺-4-(氨基甲基)氧杂-3-醇 钨,三氯羰基二(四氢呋喃)- 苏-4-羟基-5-甲氧基-3-甲基四氢呋喃-3-甲醇 艾瑞布林中间体 甲基噁丙环聚合噁丙环,醚2,4,7,9-四甲基-5-癸炔-4,7-二醇(2:1) 甲基[(氧杂戊-3-基)甲基]胺盐酸盐 甲基NA酸酐 甲基3-脱氧-D-赤式-呋喃戊糖苷 甲基2,5-脱水-3-脱氧-4-O-甲基戊酮酸酯 甲基-2,3-二脱氧-3-氟-5-O-新戊酰基-alpha-D-赤式戊呋喃糖苷 甲基(2S,5R)-5-(氯乙酰基)四氢-2-呋喃羧酸酯 甲基(2R,5S)-5-(氯乙酰基)四氢-2-呋喃羧酸酯 甲基(1S)-3-硝基-7-氧杂双环[2.2.1]庚烷-2-羧酸酯 球二孢菌素 环戊二烯基二羰基(四氢呋喃)铁(II)四氟硼酸 环十二碳六烯并[c]呋喃-1,1,3,3-四甲腈,十二氢- 环丁基-n-((四氢呋喃-2-基)甲基)甲胺 溴化镧水合物 溴三羰基(四氢呋喃)r(I)二聚体 氯化镁四氢呋喃聚合物 氯化锌四氢呋喃配合物(1:2) 氯化铪(IV)四氢呋喃络合物 氯化钴四氢呋喃聚合物 氯化钪四氢呋喃配合物 氨基甲酸,四氢-3,5-二甲基-3-呋喃基酯 正丁基(3-氰基氧杂-3-基)氨基甲酸酯 四氯化铀(四氢呋喃)3 四氢糠醇氧化钡 四氢糠基乙烯基醚 四氢呋喃钠 四氢呋喃钛酸钡(IV) 四氢呋喃溴化镁 四氢呋喃基-2-乙基酮 四氢呋喃-3-羰酰氯 四氢呋喃-3-磺酰氯 四氢呋喃-3-硼酸 四氢呋喃-3-乙酸 四氢呋喃-3,3,4,4-D4 四氢呋喃-2-羧酸-(2-乙基己基酯) 四氢呋喃-2-甲酸 (3-甲基氨基丙基)酰胺 四氢呋喃-2'-基醚 四氢-N-(3-氰基丙基)-N-甲基呋喃甲酰胺 四氢-N,N-二甲基-2-呋喃甲胺 四氢-5-甲基-5-(4-甲基-3-戊烯基)-2-呋喃醇 四氢-3-甲基-3-羟基呋喃 四氢-3-甲基-3-呋喃羧酸 四氢-3-呋喃羧酰胺 四氢-3-呋喃甲酰肼 四氢-3-呋喃基氰基乙酸酯